Vecuronium Bromide Recalled Due to Particulate Matter
January 8, 2019 – Sun Pharmaceuticals has announced a recall of three lots of Vecuronium Bromide 10mg (lyophilized powder) for injection and one lot of Vecuronium Bromide 20mg (lyophilized powder) for injection to the hospital level. Vials of the affected product contain small particulates of glass.
Although no adverse events have been reported as of the date of the recall, glass particulates in intravenous solutions can cause harm ranging from localized irritation and swelling to life-threatening events caused by blocked blood vessels.
Vecuronium bromide for injection is used as an adjunct to general anesthesia, to facilitate endotracheal intubation, and provide skeletal muscle relaxation during surgery or mechanical ventilation. It must be administered by a qualified healthcare professional.
Further information regarding the recall can be found at:
Benecard Central Fill has not been impacted by the recall.